Cargando…
The revision of the pharmaceutical legislation — it is time to act for nuclear medicine in Europe
Autores principales: | Patt, Marianne, Decristoforo, Clemens, de Martini, Amélie, Koole, Michel, Oyen, Wim J. G., Kiss, Oliver C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684671/ https://www.ncbi.nlm.nih.gov/pubmed/37867178 http://dx.doi.org/10.1007/s00259-023-06472-1 |
Ejemplares similares
-
Radionuclides: medicinal products or rather starting materials?
por: Neels, Oliver, et al.
Publicado: (2019) -
Emerging Radionuclides in a Regulatory Framework for Medicinal Products – How Do They Fit?
por: Decristoforo, Clemens, et al.
Publicado: (2021) -
Are we “preparing” radiopharmaceuticals?
por: Decristoforo, Clemens, et al.
Publicado: (2016) -
Highlights lecture EANM 2015: the search for nuclear medicine’s superheroes
por: Buck, Andreas, et al.
Publicado: (2016) -
Editorial: MEDICIS-promed: Advances in radioactive ion beams for nuclear medicine
por: Stora, Thierry, et al.
Publicado: (2022)